195 related articles for article (PubMed ID: 10851069)
21. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation.
Kitabayashi I; Yokoyama A; Shimizu K; Ohki M
EMBO J; 1998 Jun; 17(11):2994-3004. PubMed ID: 9606182
[TBL] [Abstract][Full Text] [Related]
22. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
Fliegauf M; Stock M; Berg T; Lübbert M
Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901
[TBL] [Abstract][Full Text] [Related]
23. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
[TBL] [Abstract][Full Text] [Related]
24. AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1.
Takeshita M; Ichikawa M; Nitta E; Goyama S; Asai T; Ogawa S; Chiba S; Kurokawa M
Leukemia; 2008 Jun; 22(6):1241-9. PubMed ID: 18337762
[TBL] [Abstract][Full Text] [Related]
25. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
Ando K; Griffin JD
Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
[TBL] [Abstract][Full Text] [Related]
26. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
Miller JD; Stacy T; Liu PP; Speck NA
Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
[TBL] [Abstract][Full Text] [Related]
27. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B.
Frank R; Zhang J; Uchida H; Meyers S; Hiebert SW; Nimer SD
Oncogene; 1995 Dec; 11(12):2667-74. PubMed ID: 8545124
[TBL] [Abstract][Full Text] [Related]
28. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development.
Fujita Y; Nishimura M; Taniwaki M; Abe T; Okuda T
Biochem Biophys Res Commun; 2001 Mar; 281(5):1248-55. PubMed ID: 11243869
[TBL] [Abstract][Full Text] [Related]
29. Enforced CDK4 expression in a hematopoietic cell line confers resistance to the G1 arrest induced by ionizing radiation.
Reed MF; Liu VF; Ladha MH; Ando K; Griffin JD; Weaver DT; Ewen ME
Oncogene; 1998 Dec; 17(23):2961-71. PubMed ID: 9881698
[TBL] [Abstract][Full Text] [Related]
30. [The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies].
Zuna J
Cas Lek Cesk; 2001 Mar; 140(5):131-7. PubMed ID: 11347199
[TBL] [Abstract][Full Text] [Related]
31. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.
Okumura AJ; Peterson LF; Lo MC; Zhang DE
Exp Hematol; 2007 Jun; 35(6):978-88. PubMed ID: 17533052
[TBL] [Abstract][Full Text] [Related]
32. Runx1, c-Myb, and C/EBPalpha couple differentiation to proliferation or growth arrest during hematopoiesis.
Friedman AD
J Cell Biochem; 2002; 86(4):624-9. PubMed ID: 12210729
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of AML1 renders a T hybridoma resistant to T cell receptor-mediated apoptosis.
Fujii M; Hayashi K; Niki M; Chiba N; Meguro K; Endo K; Kameoka J; Ito S; Abe K; Watanabe T; Satake M
Oncogene; 1998 Oct; 17(14):1813-20. PubMed ID: 9778047
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of leukemogenesis by AML1/EVI-1.
Mitani K
Oncogene; 2004 May; 23(24):4263-9. PubMed ID: 15156182
[TBL] [Abstract][Full Text] [Related]
35. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
Kawagoe H; Potter M; Ellis J; Grosveld GC
Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
[TBL] [Abstract][Full Text] [Related]
36. AML1 interconnected pathways of leukemogenesis.
Michaud J; Scott HS; Escher R
Cancer Invest; 2003; 21(1):105-36. PubMed ID: 12643014
[TBL] [Abstract][Full Text] [Related]
37. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates.
Adya N; Stacy T; Speck NA; Liu PP
Mol Cell Biol; 1998 Dec; 18(12):7432-43. PubMed ID: 9819429
[TBL] [Abstract][Full Text] [Related]
38. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors.
Okuda T; Cai Z; Yang S; Lenny N; Lyu CJ; van Deursen JM; Harada H; Downing JR
Blood; 1998 May; 91(9):3134-43. PubMed ID: 9558367
[TBL] [Abstract][Full Text] [Related]
39. Alterations of the AML1 transcription factor in human leukemia.
Downing JR; Higuchi M; Lenny N; Yeoh AE
Semin Cell Dev Biol; 2000 Oct; 11(5):347-60. PubMed ID: 11105899
[TBL] [Abstract][Full Text] [Related]
40. Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy.
Okuda T; Takeda K; Fujita Y; Nishimura M; Yagyu S; Yoshida M; Akira S; Downing JR; Abe T
Mol Cell Biol; 2000 Jan; 20(1):319-28. PubMed ID: 10594034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
